Dysmenorrhoea at 12 months Â
1 finding from 1 review
Improvement of the most troublesome symptom at 12 months Â
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life at 12 months Â
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Patient satisfaction at 12 monthsÂ
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events Â
1 finding from 1 review
Â
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Overall pain at 12 months Â
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of participants who were medication‐free (not using drops) at 12 months · people with open‐angle glaucoma
It is very uncertain whether phaco‐AIT changes proportion of participants who were medication‐free (not using… compared with phaco‐Trab (very low certainty).
1 finding from 1 review
Mean change in IOP measured in mmHg 12 months postintervention · people with open‐angle glaucoma
1 finding from 1 review
Mean change in number of IOP‐lowering drops from baseline · people with open‐angle glaucoma
1 finding from 1 review
Rate of visual field progression · people with open‐angle glaucoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mean change in health‐related quality of life · people with open‐angle glaucoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intraoperative and postoperative complications · people with open‐angle glaucoma
1 finding from 1 review
no estimate extracted
8 participants
Very low
Local recurrence‐free survival · women with primary breast cancer
It is very uncertain whether any O‐BCS changes local recurrence‐free survival (up to 5 years) compared with S‐BCS (very low certainty).
1 finding from 1 review
Disease-free survival · women with primary breast cancer
It is very uncertain whether any O‐BCS changes disease‐free survival compared with mastectomy (very low certainty).
1 finding from 1 review
Re‐excision rates · women with primary breast cancer
1 finding from 1 review
Complications · women with primary breast cancer
It is very uncertain whether any O‐BCS changes complications compared with mastectomy (very low certainty).
1 finding from 1 review
Recall rates · women with primary breast cancer
1 finding from 1 review
Patient‐reported outcome measures · women with primary breast cancer
1 finding from 1 review
no estimate extracted
1 study · 1 participants
GRADE not reported
Local recurrence‐free survival · women with primary breast cancer
It is very uncertain whether any O‐BCS changes local recurrence‐free survival compared with mastectomy plus reconstruction (very low certainty).
1 finding from 1 review